MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com
Analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $9.00 price target on shares of MediciNova in a research note on Friday, […]
Analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $9.00 price target on shares of MediciNova in a research note on Friday, […]
